Table 1 Clinic-pathological characteristics and univariate analysis of factors associated with OS and RFS

Sex (female vs male)

5 vs 34

1.179

0.345–4.031

0.792

1.016

0.229–4.509

0.984

Age years (≤52 vs >52)

21 vs 18

0.754

0.312–1.824

0.531

1.680

0.596–4.732

0.326

AFP (ng/ml; ≤20 vs >20)

13 vs 25

1.734

0.629–4.778

0.287

1.214

0.414–3.555

0.724

HBsAg (IU/mL; <1000 vs ≥1,000)

6 vs 28

5.915

0.784–44.637

0.085

1.561

0.340–7.179

0.567

HBeAg (negative vs positive)

33 vs 6

8.931

2.661–29.982

0.000

3.361

0.848–13.321

0.085

HBV-DNA (IU/mL; <1000 vs ≥1,000)

10 vs 9

7.798

1.580–38.496

0.012

2.808

0.647–12.186

0.168

HCV-Ab (S/CO; <10.9 vs ≥10.9)

8 vs 12

0.579

0.152–2.207

0.424

0.808

0.189–3.455

0.774

Liver cirrhosis (no vs yes)

13 vs 26

1.245

0.478–3.243

0.654

2.118

0.596–7.519

0.246

Tumor size (cm; ≤5 vs >5)

25 vs 14

4.336

1.753–10.722

0.001

2.302

0.793–6.686

0.125

Tumor number (single vs multiple)

31 vs 8

3.155

1.145–8.695

0.026

1.679

0.455–6.190

0.437

Vascular invasion (no vs yes)

26 vs 13

3.352

1.358–8.272

0.009

3.806

13.60–10.646

0.011

Capsule (no vs yes)

12 vs 26

1.319

0.474–3.670

0.596

0.775

0.259–2.317

0.648

Tumor differentiation (I-II vs III-IV)

21 vs 16

0.798

0.308–2.068

0.642

0.664

0.221–1.992

0.465